Fang Guida, Xu Dalai, Zhang Tao, Wang Gang, Qiu Lei, Gao Xuzhu, Miao Yongchang
Department of Gastrointestinal Surgery, Clinical College of Lianyungang Second People's Hospital, Bengbu Medical College, Lianyungang, China.
Department of Gastrointestinal Surgery, The Second People's Hospital of Lianyungang City, Kangda College of Nanjing Medical University, Lianyungang, China.
Front Oncol. 2023 Mar 6;13:1138481. doi: 10.3389/fonc.2023.1138481. eCollection 2023.
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide due to the lack of effective diagnosis and prognosis biomarkers and therapeutic targets, resulting in poor patient survival rates. Circular RNA (circRNA) is a type of endogenous non-coding RNA (ncRNA) with a closed-loop structure that plays a crucial role in physiological processes and pathological diseases. Recent studies indicate that circRNAs are involved in the diagnosis, prognosis, drug resistance, and development of tumors, particularly in CRC. Therefore, circRNA could be a potential new target for improving CRC diagnosis, prognosis, and treatment. This review focuses on the origin and biological functions of circRNA, summarizes recent research on circRNA's role in CRC, and discusses the potential use of circRNAs as clinical biomarkers for cancer diagnosis and prognosis, as well as therapeutic targets for CRC treatment.
由于缺乏有效的诊断和预后生物标志物以及治疗靶点,结直肠癌(CRC)是全球癌症相关死亡的主要原因,导致患者生存率较低。环状RNA(circRNA)是一种具有闭环结构的内源性非编码RNA(ncRNA),在生理过程和病理疾病中起关键作用。最近的研究表明,circRNA参与肿瘤的诊断、预后、耐药性和发展,尤其是在CRC中。因此,circRNA可能是改善CRC诊断、预后和治疗的潜在新靶点。本综述重点关注circRNA的起源和生物学功能,总结了circRNA在CRC中作用的最新研究,并讨论了circRNA作为癌症诊断和预后的临床生物标志物以及CRC治疗的治疗靶点的潜在用途。